Bioinformation Therapy for Gastric Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 30, 2017

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Advanced Gastric Cancer
Interventions
DEVICE

Cancer ablation

Tumors bigger than 2 cm are fit for ablation therapy, percutaneously under CT scan or ultrasound.

DRUG

Life information rehabilitation therapy

Each treatment: one bottle solution each day, consecutive 3 months, oral administration

Trial Locations (1)

510665

Fuda cancer institute of Fuda cancer hospital, Guangzhou

All Listed Sponsors
collaborator

Shengxin Biotechnology Institute, Beijing

OTHER

lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT03350477 - Bioinformation Therapy for Gastric Cancer | Biotech Hunter | Biotech Hunter